Redistribution Study (Fig. 1) | PTX Study (Fig. 2) | |
---|---|---|
Number of patients | 11 | 2 |
Mean Age ± S.D. (years) | 56 ± 2 (34—65) | 63—52 |
Gender | 10 M, 1 F | 2 M |
LVEF (%) ± S.D. | 20 ± 2 | 20 —20 |
Indication | 6 DCM/5 ICM | 2 ICM |
β-blocker treatment | 4/11 | 1/2 |
Aspirin treatment | 0/11 | 0/2 |
Zinterol effect on cPLA2 activity | 6, activation/ 5, inhibition | 1, activation/1, inhibition |
M, male; F, female; DCM dilated cardiomyopathy; ICM, ischemic cardiomyopathy; LVEF, left ventricular ejection fraction.